Enrollment goal reached in cardiology device study

AmeRuss is pleased to announce that 238 patients were enrolled recently in an international cardiology medical device study.

This study of the efficacy and safety of sirolimus coronary stent as compared to the everolimus coronary stent  is a prospective, randomized, multicenter trial.

AmeRuss Clinical Trials, LLC is providing full regulatory and investigational support including performance of all necessary regulatory activities, making submissions to local ethics committees and all activities related to project management, development of project plans, monitoring and logistics in Russia.The 7 participating sites in the Russian Federation include leading specialized institutions in the Central, Ural, Siberia and Far East regions.

The study sponsor manufactures products for interventional cardiology including coronary stents, coronary balloon catheters and other supplies for endovascular diagnosis and treatment of diseases of the heart and blood vessels.

Related News